Vigabatrin
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Formulations and Indications
Phase Of Development
N/A
Sponsors and Collaborators
NINDS
Mechanism of Action
Mechanism Description
Prevention of seizures in infants with Tuberous Sclerosis
Populations Tested In
Tuberous Sclerosis Complex
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link